Pentadentate MRI Contrast Agent

Technical Description

This invention presents a novel pent dentate chelate-based contrast agent for MRI, utilizing a new water-soluble ligand to enhance T1-weighted imaging. It aims to improve image contrast and diagnostic accuracy.

Problems Addressed

  • Risky Nephrogenic Systemic Fibrosis(NSF) from Gd (III) ion leaching
  • Manganese Toxicity issues
  • Mn (II) CA withdrawal
  • Coordination Complex Stability

Tech Features

  • Piperidine-carboxylate ligand
  • Provide novel metalcomplexes
  • Water soluble Mn(II)complex
  • Novel T1-weight MRI

Target Audience

  • Medical Imaging Industry
  • Pharmaceutical Industry
  • Diagnostic Imaging Centre’s
  • MRI Equipment Manufactures
  • Biomedical Research Institutions
Tech ID: P21-1250 TRL 5 Patent Status: Granted Available For Exclusive and Non-exclusive License
 Craft Display
×

P21-1250

DOWNLOAD

Send download link to email.

Contact For Licensing

Lalit Ambastha

+91- 9811367838

Dr. Medha Kaushik

+91- 6359777555

tech@ipbazzaar.com

Subscribe to Our Latest Updates!

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

Intellectual Property Rights | Technology Monetization | IP Merger & Acquisition- IP Bazzaar will use the information you provide on this form to be in touch with you and to provide updates and marketing.